Scientists and data developers behind an innovative microbiome data platform today announced their partnership with Microsoft Genomics, a Microsoft Azure service to address the computing challenges of the genomics era . It is the first Microsoft partner specialized in the microbiome genomics market.
Microbiomics is the study of the microbiome. the ecosystem of good bacteria, fungi and viruses found in virtually all living organisms. The microbiome plays a key role in disease defense, but the adoption and popularization of antibacterial products, pesticides and antibiotics over the past century has resulted in widespread microbial imbalance and deficiency. This has led to a host of problems we face today, including: immune disorders, mental health problems and antibiotic resistance.
The partnership between Eagle Genomics and Microsoft Genomics represents a commitment to meet these challenges.
Eagle Genomics' knowledge discovery platform, e [automated datatronic], uses machine learning and Azure cloud technology to turn data into actionable information that informs scientific decision-making. Partner companies can use automated data software to assess the suitability of a product for retail / consumer by, for example, assessing its impact on the complex and unique human microbiome. The information from the platform allows for a quick assessment of a product's potential, accelerated market entry, and early-stage risk reduction.
A recent Microsoft ScaleUp graduate, Eagle Genomics has extensive expertise in the conservation, analysis, and interpretation of life science data, coupled with Microsoft's Azure cloud technology and best-in-class audio technology. field. Cognitive Services provides an AI-enabled platform with significant data challenges associated with microbiome research. The platform will enable client companies to better understand this new frontier of scientific exploration, particularly its application in the areas of health, personal care, cosmetics and food.
The e [automationdatascientist] platform is already deployed in global companies such as Unilever and GSK; Eagle's collaboration with Microsoft will allow the solution to be easily customized at the corporate level through these and many other customers.
Anthony Finbow, CEO of Eagle Genomics, commented, "We are excited to be working with Microsoft Healthcare on its genomics service and look forward to working together to unleash the potential of the microbiome and solve some of the great challenges of our time. Microsoft Genomics will help us meet the challenges of computing and scaling up by accelerating the adoption of advanced technologies and technologies, launching new products and therapies, ushering in a new era of scientific discovery. "
Geralyn Miller, Director of Microsoft Genomics, added, "This collaboration with Eagle Genomics provides excellent opportunities to obtain useful information from microbiome data, a research area that, when better understood, promises to have a significant impact on our health and well-being, in line with Microsoft's mission to bring the power and breadth of the cloud to the service of precision medicine, thus covering the production of basic services and basic research . "
About Eagle Genomics
Eagle Genomics' award-winning artificial intelligence discovery platform, the computerized e-computer scientist, revolutionizes the way scientists conduct life science research and bridges the gap between data and new knowledge in ways that fast, systematic and traceable. Biologists have the data science at their fingertips to dramatically reduce research time and costs, enabling customers to achieve radical productivity improvements and true data-driven discovery.
